Cancer treatment and immune system regulation through FAT10 pathway inhibition
US10167469B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2017 |
| Grant date | Jan 1, 2019 |
| Priority date | — |
| Expiry date | Mar 30, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7028
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are methods of inhibiting mitosis, treating cancer and/or treating immune disorders through the use of agents that inhibit FAT10 and/or the FAT10 pathway.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.